Tolibut

Tolibut is a fictional medication often used in educational settings to illustrate various pharmacological principles. It is not a real drug but serves as a useful tool for teaching purposes in medical schools.
Pharmacology[edit]
Tolibut is described as a nonsteroidal anti-inflammatory drug (NSAID) with properties similar to those of ibuprofen and naproxen. It is said to work by inhibiting the cyclooxygenase (COX) enzymes, which are involved in the synthesis of prostaglandins. Prostaglandins are compounds that mediate inflammation, pain, and fever.
Mechanism of Action[edit]
Tolibut selectively inhibits the COX-2 enzyme, which is primarily responsible for the synthesis of inflammatory prostaglandins. By reducing the production of these compounds, Tolibut decreases inflammation and alleviates pain.
Pharmacokinetics[edit]
Tolibut is absorbed rapidly from the gastrointestinal tract, reaching peak plasma concentrations within 1-2 hours. It is metabolized in the liver and excreted primarily through the kidneys. The half-life of Tolibut is approximately 4-6 hours, necessitating multiple doses throughout the day for sustained effect.
Clinical Uses[edit]
In the context of medical education, Tolibut is used to demonstrate the treatment of conditions such as arthritis, musculoskeletal pain, and fever. Students learn to consider factors such as dosing, side effects, and contraindications when prescribing NSAIDs.
Side Effects[edit]
Common side effects associated with Tolibut include gastrointestinal discomfort, nausea, and headache. As with other NSAIDs, there is a risk of gastrointestinal bleeding and renal impairment with prolonged use.
Contraindications[edit]
Tolibut should not be used in patients with a history of peptic ulcer disease, renal failure, or hypersensitivity to NSAIDs. Caution is advised in patients with cardiovascular disease due to the potential for increased risk of myocardial infarction and stroke.
Related Pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian